Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.
Samsara Therapeutics's investors include FJ Labs, Apollo Health Ventures, Cambrian Biopharma, Longevitytech.fund, Healthspan Capital.
Samsara Therapeutics is headquartered in Boston, United States.
Samsara Therapeutics is a biopharmaceutical company that aims to discover therapeutics to treat rare genetic and neurodegenerative disease.
Samsara Therapeutics is at the Convertible Note stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Samsara Therapeutics — Funding & Investors." VCBacked, November 27, 2024, https://www.vcbacked.co/company/samsara-therapeutics. Accessed November 14, 2026.
VCBacked. (2024). Samsara Therapeutics — Funding & Investors. Retrieved November 14, 2026, from https://www.vcbacked.co/company/samsara-therapeutics
{{cite web |title=Samsara Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/samsara-therapeutics |website=VCBacked |access-date=November 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Samsara Therapeutics? Request a listing update